Endocyte
endocyte.comTotal trials
29
Active
1
Phase 3
2
Total enrollment
2,671
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Ovarian Cancer6
- Cancer4
- Endometrial Cancer2
- Metastatic Renal Cell Carcinoma2
- Prostate Cancer2
- Solid Tumors2
- Healthy1
- Non Small Cell Lung Cancer1
Frequently asked questions about Endocyte
- How many clinical trials does Endocyte have on ClinicalTrials.gov?
- Endocyte is listed as the lead sponsor on 29 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Endocyte's trials are in Phase 3?
- 2 of Endocyte's trials are in Phase 3.
- What therapeutic areas does Endocyte focus on?
- Endocyte's most-studied conditions on ClinicalTrials.gov are Ovarian Cancer, Cancer, Endometrial Cancer, Metastatic Renal Cell Carcinoma, Prostate Cancer.